Found: 73
Select item for more details and to access through your institution.
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2030, doi. 10.3390/cancers16112030
- By:
- Publication type:
- Article
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 203, doi. 10.3390/v16020203
- By:
- Publication type:
- Article
Associations between Nutrigenomic Effects and Incidences of Microbial Resistance against Novel Antibiotics.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 8, p. 1093, doi. 10.3390/ph16081093
- By:
- Publication type:
- Article
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1469, doi. 10.3390/biomedicines11051469
- By:
- Publication type:
- Article
Application of DNA Replicons in Gene Therapy and Vaccine Development.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 947, doi. 10.3390/pharmaceutics15030947
- By:
- Publication type:
- Article
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 698, doi. 10.3390/v15030698
- By:
- Publication type:
- Article
SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach.
- Published in:
- Inflammation, 2023, v. 46, n. 1, p. 297, doi. 10.1007/s10753-022-01734-w
- By:
- Publication type:
- Article
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 208, doi. 10.3390/vaccines11020208
- By:
- Publication type:
- Article
COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 214, doi. 10.3390/vaccines11020214
- By:
- Publication type:
- Article
Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15622, doi. 10.3390/ijms232415622
- By:
- Publication type:
- Article
Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/v14102105
- By:
- Publication type:
- Article
Alphaviruses in Immunotherapy and Anticancer Therapy.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2263, doi. 10.3390/biomedicines10092263
- By:
- Publication type:
- Article
Packaging, Purification, and Titration of Replication-Deficient Semliki Forest Virus-Derived Particles as a Self-Amplifying mRNA Vaccine Vector.
- Published in:
- Iranian Biomedical Journal, 2022, v. 26, n. 4, p. 269, doi. 10.52547/ibj.3535
- By:
- Publication type:
- Article
Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 5, p. 910, doi. 10.3390/v14050910
- By:
- Publication type:
- Article
An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.13136
- By:
- Publication type:
- Article
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site.
- Published in:
- Frontiers in Virology, 2022, p. 1, doi. 10.3389/fviro.2022.834808
- By:
- Publication type:
- Article
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1187, doi. 10.3390/vaccines9101187
- By:
- Publication type:
- Article
Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
COVID-19 in 2021.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 10, p. 2098, doi. 10.3390/v13102098
- By:
- Publication type:
- Article
The structural basis of accelerated host cell entry by SARS‐CoV‐2†.
- Published in:
- FEBS Journal, 2021, v. 288, n. 17, p. 5010, doi. 10.1111/febs.15651
- By:
- Publication type:
- Article
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 1020, doi. 10.3390/biom11071020
- By:
- Publication type:
- Article
Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
- Published in:
- Biomedicines, 2021, v. 9, n. 5, p. 556, doi. 10.3390/biomedicines9050556
- By:
- Publication type:
- Article
From Multiplex Serology to Serolomics—A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 749, doi. 10.3390/v13050749
- By:
- Publication type:
- Article
Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 927, doi. 10.3390/v13050927
- By:
- Publication type:
- Article
Amantadine Inhibits SARS-CoV-2 In Vitro.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 539, doi. 10.3390/v13040539
- By:
- Publication type:
- Article
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 558, doi. 10.3390/v13040558
- By:
- Publication type:
- Article
A Strong Seasonality Pattern for Covid-19 Incidence Rates Modulated by UV Radiation Levels.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 574, doi. 10.3390/v13040574
- By:
- Publication type:
- Article
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 609, doi. 10.3390/v13040609
- By:
- Publication type:
- Article
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 651, doi. 10.3390/v13040651
- By:
- Publication type:
- Article
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 700, doi. 10.3390/v13040700
- By:
- Publication type:
- Article
Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks †.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Questions concerning the proximal origin of SARS‐CoV‐2.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1204, doi. 10.1002/jmv.26478
- By:
- Publication type:
- Article
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 413, doi. 10.3390/v13030413
- By:
- Publication type:
- Article
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 418, doi. 10.3390/v13030418
- By:
- Publication type:
- Article
The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 425, doi. 10.3390/v13030425
- By:
- Publication type:
- Article
Treatment Protocol for COVID-19 Based on T2R Phenotype.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 503, doi. 10.3390/v13030503
- By:
- Publication type:
- Article
Structure-Based Identification of Natural Products as SARS-CoV-2 M pro Antagonist from Echinacea angustifolia Using Computational Approaches.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 305, doi. 10.3390/v13020305
- By:
- Publication type:
- Article
Viral Vectors for COVID-19 Vaccine Development.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 317, doi. 10.3390/v13020317
- By:
- Publication type:
- Article
Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 322, doi. 10.3390/v13020322
- By:
- Publication type:
- Article
Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 329, doi. 10.3390/v13020329
- By:
- Publication type:
- Article
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 1, p. 54, doi. 10.3390/v13010054
- By:
- Publication type:
- Article
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 1, p. 109, doi. 10.3390/v13010109
- By:
- Publication type:
- Article
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 5906, doi. 10.3390/molecules25245906
- By:
- Publication type:
- Article
The Importance of Research on the Origin of SARS-CoV-2.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 11, p. 1324, doi. 10.3390/v12111324
- By:
- Publication type:
- Article
Are Viral Vectors Any Good for RNAi Antiviral Therapy? †.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Viral Vectors Applied for RNAi-Based Antiviral Therapy.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 9, p. 924, doi. 10.3390/v12090924
- By:
- Publication type:
- Article
Self-Amplifying RNA Viruses as RNA Vaccines.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 5130, doi. 10.3390/ijms21145130
- By:
- Publication type:
- Article
Coronavirus Pandemic—Therapy and Vaccines.
- Published in:
- Biomedicines, 2020, v. 8, n. 5, p. 109, doi. 10.3390/biomedicines8050109
- By:
- Publication type:
- Article
Viral Vector-Based Melanoma Gene Therapy.
- Published in:
- Biomedicines, 2020, v. 8, n. 3, p. 60, doi. 10.3390/biomedicines8030060
- By:
- Publication type:
- Article